- 同花顺特色产品
- 〈高级诊股〉 全方位深度分析，提供明确投资建议
- 短期趋势：
短期行情可能回暖，可适量买进股票，作短线反弹行情。
- 中期趋势：
有加速下跌的趋势。
- 长期趋势：
已有11家主力机构披露2026-06-30报告期持股数据，持仓量总计410.03万股，占流通A股0.52%
- 波段诊断：
-
技术面诊股
诊断结果：3.2技术面打败了5%的股票
技术面评分前10的股票
近期的平均成本为3.20元。空头行情中，并且有加速下跌的趋势。
平均成本
近期的平均成本为3.20元。
[{"text":"\u5e73\u5747\u6210\u672c","value":"3.20","date":1792657247,"color":"0x9f0ba1"}]
市场表现
过去10个交易日，该股走势明显跑输大盘，跑输行业平均水平。
[{"date":"2026.10.23","stock":"1.23","trade":"0.88","ind":"0.89"},{"date":"2026.10.22","stock":"-3.83","trade":"-2.52","ind":"-1.48"},{"date":"2026.10.21","stock":"0.30","trade":"-0.15","ind":"-0.60"},{"date":"2026.10.20","stock":"0.00","trade":"-0.28","ind":"0.12"},{"date":"2026.10.19","stock":"-2.03","trade":"0.26","ind":"0.39"},{"date":"2026.10.16","stock":"-0.58","trade":"-0.12","ind":"0.24"},{"date":"2026.10.15","stock":"-1.42","trade":"-1.40","ind":"-1.59"},{"date":"2026.10.14","stock":"-1.68","trade":"-0.46","ind":"-0.88"},{"date":"2026.10.13","stock":"1.13","trade":"-0.13","ind":"0.10"},{"date":"2026.10.12","stock":"-3.80","trade":"-1.56","ind":"-0.43"},{"date":"2026.10.09","stock":"2.51","trade":"2.04","ind":"0.05"},{"date":"2026.10.08","stock":"-1.37","trade":"-0.69","ind":"-0.79"},{"date":"2026.09.30","stock":"1.11","trade":"1.21","ind":"0.31"},{"date":"2026.09.29","stock":"0.00","trade":"-0.13","ind":"0.18"},{"date":"2026.09.28","stock":"-0.28","trade":"-0.22","ind":"-1.67"},{"date":"2026.09.24","stock":"-1.63","trade":"-1.25","ind":"-1.22"},{"date":"2026.09.23","stock":"-2.91","trade":"-1.22","ind":"-0.39"},{"date":"2026.09.22","stock":"-1.05","trade":"-0.02","ind":"0.06"},{"date":"2026.09.21","stock":"7.30","trade":"3.26","ind":"0.97"},{"date":"2026.09.18","stock":"0.56","trade":"0.53","ind":"0.94"},{"date":"2026.09.17","stock":"0.85","trade":"0.47","ind":"-0.41"}]
益佰制药,上证指数,中药指数
压力支撑
该股压力位为3.19元，支撑位为3.07元。
[{"text":"\u538b\u529b\u4f4d","value":"3.19","date":1792684800,"color":"0x9f0ba1"},{"text":"\u652f\u6491\u4f4d","value":"3.07","date":1792684800,"color":"0x0b52a1"}]
多空趋势
空头行情中，并且有加速下跌的趋势。
macd
kdj
boll
asi
bias
rsi
wr
vr
资金面诊股
诊断结果：4.0资金面打败了55%的股票
主力控盘前10的股票
行业资金
中药行业， 近5日资金总体呈流出状态，请投资者谨慎关注该行业的个股。
更新时间：10月23日 20:31
| 机构今日流向(万元) | 572.27 | 机构5日流向(万元) | -1726.37 |
| 机构10日流向(万元) | -4309.32 | 机构20日流向(万元) | -3965.67 |
机构持仓
2026-06-30 与 2025-12-31 相比，主力机构持仓量减少413.46万股，其中基金净减仓1家，主力净减仓13家，请投资者中长期谨慎为宜。
截止2026-06-30，共11家主力机构（基金11家），持仓量总计410.03万股，占流通A股0.52%
其中，基金持仓与2025-12-31相比：
增仓：3家 ，增持 82.84万股
减仓：4家 ，减持 59.69万股
新出现在主力名单中：4家 ，持有223.96万股
从主力名单中消失：17家 ，原持有660.57万股
其中，基金持仓与2025-12-31相比：
增仓：3家 ，增持 82.84万股
减仓：4家 ，减持 59.69万股
新出现在主力名单中：4家 ，持有223.96万股
从主力名单中消失：17家 ，原持有660.57万股
消息面诊股
诊断结果：3.3消息面打败了0%的股票
今日有利好新闻的公司
近期该股利空消息较多，投资时需谨慎。
更多>>个股资讯
- 益佰制药：10月22日获融资买入319.81万元
2026-10-23 - 益佰制药：10月21日获融资买入425.51万元
2026-10-22 - 益佰制药：10月20日获融资买入351.70万元
2026-10-21 - 益佰制药：10月19日获融资买入343.93万元
2026-10-20 - 益佰制药：10月16日获融资买入476.28万元
2026-10-17 - 益佰制药：10月15日获融资买入298.67万元
2026-10-16 - 益佰制药：10月14日获融资买入364.01万元
2026-10-15 - 益佰制药：10月13日获融资买入338.52万元
2026-10-14 - 益佰制药：10月12日获融资买入717.97万元
2026-10-13 - 益佰制药：10月9日获融资买入558.57万元
2026-10-10
消息列表
| 一般消息 | 分红转增 | 不分配不转增 | 2026-08-21 |
| 利空 | 重大事项 | 公司违规：处罚类型 | 2026-08-01 |
| 重大利空 | 业绩预告 | 预计增亏 | 2026-07-15 |
| 一般消息 | 股东大会 | 临时股东大会 | 2026-06-17 |
| 一般消息 | 分红转增 | 不分配不转增 | 2026-04-23 |
| 一般消息 | 募资投向 | 公司购买资产 | 2026-04-23 |
| 重大利空 | 业绩预告 | 预计续亏 | 2026-01-22 |
| 重大利空 | 业绩预告 | 预计续亏 | 2026-01-13 |
| 一般消息 | 重大事项 | 公司股东股份解押 | 2025-11-28 |
| 一般消息 | 高管变动 | 个人原因 | 2025-11-26 |
一年消息统计
| 所有消息 | 重大消息 | 非重大消息 | |
| 利好 | 0条 | 0条 | 0条 |
| 利空 | 4条 | 3条 | 1条 |
行业面诊股
诊断结果：5.8行业面打败了83%的股票
中药行业最新资金流向
近10日来该行业走势总体向下，跑输大盘。最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
行业走势
近10日来该行业走势总体向下，跑输大盘。
[{"date":"2026.10.23","price":"0.89","value":"0.88"},{"date":"2026.10.22","price":"-1.48","value":"-2.52"},{"date":"2026.10.21","price":"-0.60","value":"-0.15"},{"date":"2026.10.20","price":"0.12","value":"-0.28"},{"date":"2026.10.19","price":"0.39","value":"0.26"},{"date":"2026.10.16","price":"0.24","value":"-0.12"},{"date":"2026.10.15","price":"-1.59","value":"-1.40"},{"date":"2026.10.14","price":"-0.88","value":"-0.46"},{"date":"2026.10.13","price":"0.10","value":"-0.13"},{"date":"2026.10.12","price":"-0.43","value":"-1.56"},{"date":"2026.10.09","price":"0.05","value":"2.04"},{"date":"2026.10.08","price":"-0.79","value":"-0.69"},{"date":"2026.09.30","price":"0.31","value":"1.21"},{"date":"2026.09.29","price":"0.18","value":"-0.13"},{"date":"2026.09.28","price":"-1.67","value":"-0.22"},{"date":"2026.09.24","price":"-1.22","value":"-1.25"},{"date":"2026.09.23","price":"-0.39","value":"-1.22"},{"date":"2026.09.22","price":"0.06","value":"-0.02"},{"date":"2026.09.21","price":"0.97","value":"3.26"},{"date":"2026.09.18","price":"0.94","value":"0.53"},{"date":"2026.09.17","price":"-0.41","value":"0.47"}]
上证指数,中药行业
行业排名
| 排名 | 股票名称 | 1月涨跌幅 | 5日涨跌幅 | 评分 |
|---|---|---|---|---|
| 1 | 达仁堂 | 20.68% | 10.43% | 6.3分 |
| 2 | ST万邦 | 14.94% | -4.43% | 5.5分 |
| 3 | 昆药集团 | 8.63% | 4.88% | 6.0分 |
| 4 | 马应龙 | 8.29% | -1.14% | 5.9分 |
| 5 | 新光药业 | 8.05% | 2.87% | 5.9分 |
| 6 | 恩威医药 | 7.55% | 6.98% | 5.6分 |
| 8 | 同仁堂 | 6.12% | 1.15% | 5.9分 |
| 10 | 片仔癀 | 5.46% | 2.00% | 6.2分 |
| 12 | 济川药业 | 4.85% | 1.50% | 6.6分 |
| 14 | 亚宝药业 | 3.94% | 0.29% | 6.0分 |
| 16 | 康缘药业 | 3.48% | 1.21% | 6.0分 |
| 18 | 东阿阿胶 | 3.05% | -1.16% | 6.1分 |
| 20 | 奇正藏药 | 1.42% | 0.78% | 5.8分 |
| 22 | 寿仙谷 | 1.29% | -0.70% | 5.7分 |
| 24 | 步长制药 | 1.23% | 1.93% | 5.9分 |
| 26 | 健民集团 | 0.92% | -3.36% | 5.6分 |
| 28 | 华森制药 | 0.74% | -6.17% | 5.0分 |
| 30 | 太极集团 | 0.45% | 2.99% | 5.8分 |
| 32 | 桂林三金 | 0.00% | -0.98% | 5.9分 |
| 34 | 康恩贝 | -0.47% | -1.41% | 5.5分 |
| 36 | 吉林敖东 | -1.29% | -0.06% | 5.4分 |
| 38 | 仁和药业 | -1.74% | -0.78% | 5.5分 |
| 40 | 上海凯宝 | -2.78% | -2.58% | 4.9分 |
| 42 | ST葫芦娃 | -3.50% | -1.43% | 4.1分 |
| 44 | 信邦制药 | -3.78% | -1.75% | 5.3分 |
| 46 | 华神科技 | -4.08% | -5.76% | 5.3分 |
| 48 | - | -4.50% | 0.00% | 分 |
| 50 | 千金药业 | -5.40% | -3.89% | 5.1分 |
| 52 | 益盛药业 | -6.13% | -3.80% | 5.0分 |
| 54 | 益佰制药 | -6.78% | -4.35% | 4.0分 |
| 56 | 珍宝岛 | -8.29% | -3.37% | 4.9分 |
| 58 | 维康药业 | -10.29% | 1.86% | 4.3分 |
| 60 | ST嘉应 | -12.70% | -3.58% | 4.4分 |
| 62 | 太龙药业 | -14.08% | -6.60% | 4.4分 |
| 64 | 汉森制药 | -14.45% | -8.12% | 4.6分 |
| 66 | 康惠股份 | -16.62% | -5.07% | 5.1分 |
| 68 | *ST香雪 | -36.22% | -19.84% | 4.7分 |
行业评级
最近120个交易日，机构评级以增持为主，认为该行业有一定投资价值。
- 综合评级
| 研究机构 | 评级日期 | 最新评级 | 上次评级 |
| 中信证券 | 2012-09-10 | 增持 | 增持 |
| 招商证券 | 2012-09-08 | 增持 | 增持 |
| 航天证券 | 2012-09-06 | 增持 | - |
| 中银国际 | 2012-09-05 | 增持 | - |
| 齐鲁证券 | 2012-09-05 | 增持 | - |
更多>>行业资讯
- 2012-09-13亿利能源股权质押登记
- 2012-09-13太极集团修改《公司章程》
- 2012-09-13人福医药获得国家补助资金
- 2012-09-13常山药业：归还暂时用于补充流动资金的闲置募集资金
- 2012-09-13贵州百灵：公司与济南百诺医药科技开发有限公司签订技
- 2012-09-13振东制药山西省第三建筑工程公司承建山西振东泰盛制药
- 2012-09-13双成药业：战略合作框架协议进展
- 2012-09-13佛慈制药：签订推荐恢复上市、委托代办股份转让协议
- 2012-09-13昊海生科IPO资产被疑是大江股份上市募投项目
- 2012-09-13泰格医药涨势猛 业务有望快速扩张
基本面诊股
[ 截止日期：2026-06-30 ]公司经营
盈利能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 62/110 ， 28/110。
[{"date":"2026-06-30","value":"-3.74","vol":"3.25"},{"date":"2026-03-31","value":"-1.36","vol":"2.21"},{"date":"2025-12-31","value":"-14.09","vol":"-2.33"},{"date":"2025-09-30","value":"-3.54","vol":"4.80"},{"date":"2025-06-30","value":"-0.80","vol":"4.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净资产收 益率(%) |
-3.74 | -1.36 | -14.09 | -3.54 | -0.80 |
| 行业(%) | 3.25 | 2.21 | -2.33 | 4.80 | 4.03 |
该指标值越高，盈利能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"57.67","vol":"53.70"},{"date":"2026-03-31","value":"57.92","vol":"55.05"},{"date":"2025-12-31","value":"59.66","vol":"52.85"},{"date":"2025-09-30","value":"60.32","vol":"53.29"},{"date":"2025-06-30","value":"60.65","vol":"53.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 销售毛利 率(%) |
57.67 | 57.92 | 59.66 | 60.32 | 60.65 |
| 行业(%) | 53.70 | 55.05 | 52.85 | 53.29 | 53.82 |
该指标值越高，盈利能力越强，行业排名越靠前。
成长能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 61/110 ， 64/110。
[{"date":"2026-06-30","value":"-30.58","vol":"-9.08"},{"date":"2026-03-31","value":"-28.44","vol":"-5.58"},{"date":"2025-12-31","value":"-14.31","vol":"-6.76"},{"date":"2025-09-30","value":"-15.59","vol":"-7.84"},{"date":"2025-06-30","value":"-14.99","vol":"-7.78"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 营业收入同 比增长率(%) |
-30.58 | -28.44 | -14.31 | -15.59 | -14.99 |
| 行业(%) | -9.08 | -5.58 | -6.76 | -7.84 | -7.78 |
该指标值越高，成长能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"-303.67","vol":"-101.51"},{"date":"2026-03-31","value":"-214.57","vol":"1.06"},{"date":"2025-12-31","value":"-3.89","vol":"-80.25"},{"date":"2025-09-30","value":"48.83","vol":"-2.78"},{"date":"2025-06-30","value":"81.31","vol":"2.25"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 净利润同比 增长率(%) |
-303.67 | -214.57 | -3.89 | 48.83 | 81.31 |
| 行业(%) | -101.51 | 1.06 | -80.25 | -2.78 | 2.25 |
该指标值越高，成长能力越强，行业排名越靠前。
营运能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 36/110 ， 56/110。
[{"date":"2026-06-30","value":"0.21","vol":"0.22"},{"date":"2026-03-31","value":"0.10","vol":"0.12"},{"date":"2025-12-31","value":"0.49","vol":"0.47"},{"date":"2025-09-30","value":"0.36","vol":"0.35"},{"date":"2025-06-30","value":"0.24","vol":"0.24"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 总资产周 转率(次) |
0.21 | 0.10 | 0.49 | 0.36 | 0.24 |
| 行业(次) | 0.22 | 0.12 | 0.47 | 0.35 | 0.24 |
该指标值越高，营运能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.54","vol":"1.14"},{"date":"2026-03-31","value":"0.28","vol":"0.59"},{"date":"2025-12-31","value":"1.30","vol":"2.34"},{"date":"2025-09-30","value":"1.00","vol":"1.72"},{"date":"2025-06-30","value":"0.66","vol":"1.17"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 存货增长 率(次) |
0.54 | 0.28 | 1.30 | 1.00 | 0.66 |
| 行业(次) | 1.14 | 0.59 | 2.34 | 1.72 | 1.17 |
该指标值越高，营运能力越强，行业排名越靠前。
现金流能力：偏弱，与行业平均有较大差距，两项指标的行业排名分别为 49/110 ， 8/110。
[{"date":"2026-06-30","value":"5.74","vol":"20.65"},{"date":"2026-03-31","value":"12.59","vol":"5.83"},{"date":"2025-12-31","value":"12.71","vol":"30.77"},{"date":"2025-09-30","value":"7.33","vol":"10.53"},{"date":"2025-06-30","value":"33.16","vol":"22.82"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 现金流量净额/营业收入 | 5.74 | 12.59 | 12.71 | 7.33 | 33.16 |
| 行业 | 20.65 | 5.83 | 30.77 | 10.53 | 22.82 |
该指标值越高，现金流能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.16","vol":"0.88"},{"date":"2026-03-31","value":"","vol":"0.00"},{"date":"2025-12-31","value":"0.18","vol":"1.00"},{"date":"2025-09-30","value":"","vol":"0.00"},{"date":"2025-06-30","value":"0.14","vol":"1.03"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资本支出／折旧和摊销 | 0.16 | - | 0.18 | - | 0.14 |
| 行业 | 0.88 | 0.00 | 1.00 | 0.00 | 1.03 |
该指标值越低，现金流能力越强，行业排名越靠前。
短期偿债能力：很强，位居行业前列,建议强烈关注，两项指标的行业排名分别为 11/110 ， 2/110。
[{"date":"2026-06-30","value":"1.70","vol":"3.10"},{"date":"2026-03-31","value":"1.70","vol":"2.97"},{"date":"2025-12-31","value":"1.59","vol":"2.94"},{"date":"2025-09-30","value":"1.88","vol":"3.09"},{"date":"2025-06-30","value":"1.80","vol":"2.94"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 流动比率 |
1.70 | 1.70 | 1.59 | 1.88 | 1.80 |
| 行业 | 3.10 | 2.97 | 2.94 | 3.09 | 2.94 |
该指标值越接近2，短期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.95","vol":"2.34"},{"date":"2026-03-31","value":"1.01","vol":"2.23"},{"date":"2025-12-31","value":"0.94","vol":"2.15"},{"date":"2025-09-30","value":"1.16","vol":"2.24"},{"date":"2025-06-30","value":"1.14","vol":"2.15"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 速动比率 |
0.95 | 1.01 | 0.94 | 1.16 | 1.14 |
| 行业 | 2.34 | 2.23 | 2.15 | 2.24 | 2.15 |
该指标值越接近1，短期偿债能力越强，行业排名越靠前。
长期偿债能力：尚可，接近行业平均，可适当关注，两项指标的行业排名分别为 22/110 ， 28/110。
[{"date":"2026-06-30","value":"32.90","vol":"32.07"},{"date":"2026-03-31","value":"34.03","vol":"31.94"},{"date":"2025-12-31","value":"34.03","vol":"32.43"},{"date":"2025-09-30","value":"34.46","vol":"31.59"},{"date":"2025-06-30","value":"36.24","vol":"32.45"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 资产负债 率(%) |
32.90 | 34.03 | 34.03 | 34.46 | 36.24 |
| 行业(%) | 32.07 | 31.94 | 32.43 | 31.59 | 32.45 |
该指标值越接近50%，长期偿债能力越强，行业排名越靠前。
[{"date":"2026-06-30","value":"0.51","vol":"0.68"},{"date":"2026-03-31","value":"0.54","vol":"0.66"},{"date":"2025-12-31","value":"0.54","vol":"0.67"},{"date":"2025-09-30","value":"0.55","vol":"0.76"},{"date":"2025-06-30","value":"0.59","vol":"0.75"}]
| 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | |
|---|---|---|---|---|---|
| 产权比率 (%) |
0.51 | 0.54 | 0.54 | 0.55 | 0.59 |
| 行业(%) | 0.68 | 0.66 | 0.67 | 0.76 | 0.75 |
该指标值越高，长期偿债能力越强，行业排名越靠前。
机构预测
暂时还没有机构预测该股2026年的收益，请投资者后续关注。
[{"date":"2022","yellowRectValue":"-4.26","blueLineValue":"","type":""},{"date":"2023","yellowRectValue":"1.03","blueLineValue":"","type":""},{"date":"2024","yellowRectValue":"-3.17","blueLineValue":"","type":""},{"date":"2025","yellowRectValue":"-3.30","blueLineValue":"","type":""},{"date":"2026","yellowRectValue":"0.00","blueLineValue":"","type":"YC"}]